HCG Bengaluru pushes distress screening as ‘6th vital sign’ in cancer care
The initiative aligns with global psycho-oncology standards that advocate routine distress screening as a core quality benchmark in cancer treatment
The initiative aligns with global psycho-oncology standards that advocate routine distress screening as a core quality benchmark in cancer treatment
The Phase 3 trial will be conducted under the auspices of the first Regenerative Medicine Advanced Therapy (RMAT) designation approved by the USFDA for an EV therapeutic
Ampion is directly administered by inhalation and it allows the drug to directly target and attenuate inflammation in the lungs
Tecentriq SC reduces treatment administration time by nearly 80 percent and has the potential to lower indirect treatment costs
Marking World Asthma Day 2026, doctors sounded the alarm over a steady surge in respiratory illnesses
The ETHICON 4000 Stapler and ETHICON 3D Reloads are now approved for use in both open and laparoscopic surgeries across the European Union
Medherant’s testosterone TEPI Patch could become the first-in-class testosterone patch developed specifically for women
Long-term OGSIVEO treatment for up to four years associated with further tumor reductions, increased objective response rate, sustained symptom improvement, and consistent safety profile
This predictive technology empowers people with diabetes to take preventive action before complications arise
Subscribe To Our Newsletter & Stay Updated